Market Cap 609.12B
Revenue (ttm) 94.19B
Net Income (ttm) 26.80B
EPS (ttm) N/A
PE Ratio 23.02
Forward PE 21.40
Profit Margin 28.46%
Debt to Equity Ratio 0.46
Volume 3,591,084
Avg Vol 8,366,368
Day's Range N/A - N/A
Shares Out 2.41B
Stochastic %K 30%
Beta 0.24
Analysts Strong Sell
Price Target $270.20

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospit...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 732 524 0400
Website: www.jnj.com
Address:
One Johnson & Johnson Plaza, New Brunswick, United States
Alex7000
Alex7000 Jul. 20 at 4:23 PM
$ATAI Whether $JNJ will actually stand idly by and allow a direct threat to its blockbuster Spravato to grow under its competitor $LLY ?!
0 · Reply
Suite510
Suite510 Jul. 20 at 4:02 PM
$JNJ $KVUE Rut Ro lol 😂 🙈 breaking news Talcum Powder PSC Says It Intends to Seek Reinstatement of Specific Causation Experts for Bellwether Cases in the Talc MDL
1 · Reply
Stockprofiler
Stockprofiler Jul. 20 at 12:26 PM
$AIMN The right network. The right context. @AimwellBIO Observer connects serious healthcare professionals to trusted signals, curated intelligence, and a verified network built for the future of healthcare. Apply free. Stay in the network. http://aimwellbio.com/observer-signup $AIMN #pharma $PFE $JNJ $MEDI
0 · Reply
GoforProMIS
GoforProMIS Jul. 20 at 11:16 AM
$PMN Listing of PMN310 Platform where we are targeting following diseases and revenues: 1. Schizophrenia (Schizophrenie) Pharmaceutical sales 2026: approx. 7.80 to 9.48 billion USD Leading companies (market leaders): OTSUKS Pharmaceutical & H. $LUNDBECK (co-marketing Rexulti / Abilify Maintena) $JNJ Johnson (Janssen) (market leader in long-acting depot injections such as Invega Sustenna/Trinza) $BMY Bristol Myers Squibb (BMS) (via the acquisition of Karuna Therapeutics, owner of Cobenfy, the first antipsychotic blockbuster with a novel muscarinic mechanism of action) $ALKS (specializing in injectable therapies such as Aristada and Lybalvi)
0 · Reply
Diefreeandsell
Diefreeandsell Jul. 20 at 10:30 AM
$IBRX Jimmy say’s it’s no longer just a spec buy put this one in your long term portfolio and hold. De-risked and better than $JNJ , grandpa’s stock. Ibrx Entering hyper growth phase!
2 · Reply
MGPgps00940B
MGPgps00940B Jul. 20 at 8:37 AM
$SLS $JNJ I'm possitive the executives of JNJ already know who John Burns and Anson are. I'm sure they already know what happened after the last FOX interview January 2025 and the huge offering after that interview.
0 · Reply
MarlonJohn
MarlonJohn Jul. 19 at 7:24 PM
Retest validation! $JNJ triggers a perfect weekly breakout bounce as the healthcare titan shifts gears! Healthcare behemoth Johnson & Johnson ($JNJ) completes its tight technical consolidation, closing strong at $253.04 (+1.23% d/d) after touching an intraday peak of $255.66. Following a localized macro rotation out of high-beta tech, defensively minded capital is fortifying JNJ's structural base underneath its recent $269.43 high. Textbook macro technical framework! The weekly tape has executed a pristine breakout and retest sequence. After initially piercing its long-term overhead ceiling, the price underwent a highly constructive checkback to solidify the breakout zone as iron-clad demand shelf. Now that the weekly candle has officially registered a powerful reactive bounce from this inflection node, the bearish trap is verified closed. Velocity models indicate buying flow will naturally accelerate right-side momentum into a sustained short squeeze.
0 · Reply
Suite510
Suite510 Jul. 19 at 4:54 PM
$JNJ $KVUE In the past year alone, juries have awarded a $1.5 billion verdict in Baltimore, a $966 million verdict in Los Angeles later reduced to $16 million, a $40 million ovarian cancer verdict in Los Angeles, a $32 million mesothelioma verdict in Los Angeles, and a $65.5 million mesothelioma verdict in Minnesota—all finding that J&J's talccausing the plaintiffs' cancers.
1 · Reply
Suite510
Suite510 Jul. 19 at 4:52 PM
$JNJ $KVUE Shake n Bake Junk n Junk MDL talc trials start August 3rd in NJ 🤣🙈
1 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Jul. 19 at 4:03 PM
$SLS $MRK $ABBV $JNJ $PFE Part 3. I wouldn’t be surprised one ☝️ Bit if patent expiring in the tune of $380 Billion big pharmaceuticals make a move before Dr. Angelos Stergiou appearance at Fox and Friends. Once GPS CURATIVE news is televised on US # 1 News Network Show it will be hard to contain the SLS KRAKEN. Trading will be halted before any BO PR! ✌️🙏❤️‍🩹
0 · Reply
Latest News on JNJ
DePuy Synthes Acquires Expanding Innovations™

Jul 16, 2026, 8:00 AM EDT - 4 days ago

DePuy Synthes Acquires Expanding Innovations™


Johnson & Johnson Earnings Call Transcript: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 5 days ago

Johnson & Johnson Earnings Call Transcript: Q2 2026


Johnson & Johnson Slides: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 5 days ago

Johnson & Johnson Slides: Q2 2026


Johnson & Johnson Earnings release: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 5 days ago

Johnson & Johnson Earnings release: Q2 2026


Johnson & Johnson Hikes Guidance, Stock Falls

Jul 15, 2026, 6:35 AM EDT - 5 days ago

Johnson & Johnson Hikes Guidance, Stock Falls


Johnson & Johnson Bumps Up Guidance as Sales Rise

Jul 15, 2026, 6:33 AM EDT - 5 days ago

Johnson & Johnson Bumps Up Guidance as Sales Rise


The Big 3: UNH, KO, JNJ

Jul 9, 2026, 1:00 PM EDT - 11 days ago

The Big 3: UNH, KO, JNJ

KO UNH


Johnson & Johnson to Buy Firefly Bio for $1 Billion

Jun 8, 2026, 9:01 AM EDT - 6 weeks ago

Johnson & Johnson to Buy Firefly Bio for $1 Billion


Johnson & Johnson to buy Firefly Bio for $1 billion

Jun 8, 2026, 8:08 AM EDT - 6 weeks ago

Johnson & Johnson to buy Firefly Bio for $1 billion


Johnson & Johnson says nipocalimab approved in China

May 21, 2026, 4:31 AM EDT - 2 months ago

Johnson & Johnson says nipocalimab approved in China


CVS to drop J&J's Stelara from its main formularies

May 5, 2026, 9:15 AM EDT - 2 months ago

CVS to drop J&J's Stelara from its main formularies

CVS


Alex7000
Alex7000 Jul. 20 at 4:23 PM
$ATAI Whether $JNJ will actually stand idly by and allow a direct threat to its blockbuster Spravato to grow under its competitor $LLY ?!
0 · Reply
Suite510
Suite510 Jul. 20 at 4:02 PM
$JNJ $KVUE Rut Ro lol 😂 🙈 breaking news Talcum Powder PSC Says It Intends to Seek Reinstatement of Specific Causation Experts for Bellwether Cases in the Talc MDL
1 · Reply
Stockprofiler
Stockprofiler Jul. 20 at 12:26 PM
$AIMN The right network. The right context. @AimwellBIO Observer connects serious healthcare professionals to trusted signals, curated intelligence, and a verified network built for the future of healthcare. Apply free. Stay in the network. http://aimwellbio.com/observer-signup $AIMN #pharma $PFE $JNJ $MEDI
0 · Reply
GoforProMIS
GoforProMIS Jul. 20 at 11:16 AM
$PMN Listing of PMN310 Platform where we are targeting following diseases and revenues: 1. Schizophrenia (Schizophrenie) Pharmaceutical sales 2026: approx. 7.80 to 9.48 billion USD Leading companies (market leaders): OTSUKS Pharmaceutical & H. $LUNDBECK (co-marketing Rexulti / Abilify Maintena) $JNJ Johnson (Janssen) (market leader in long-acting depot injections such as Invega Sustenna/Trinza) $BMY Bristol Myers Squibb (BMS) (via the acquisition of Karuna Therapeutics, owner of Cobenfy, the first antipsychotic blockbuster with a novel muscarinic mechanism of action) $ALKS (specializing in injectable therapies such as Aristada and Lybalvi)
0 · Reply
Diefreeandsell
Diefreeandsell Jul. 20 at 10:30 AM
$IBRX Jimmy say’s it’s no longer just a spec buy put this one in your long term portfolio and hold. De-risked and better than $JNJ , grandpa’s stock. Ibrx Entering hyper growth phase!
2 · Reply
MGPgps00940B
MGPgps00940B Jul. 20 at 8:37 AM
$SLS $JNJ I'm possitive the executives of JNJ already know who John Burns and Anson are. I'm sure they already know what happened after the last FOX interview January 2025 and the huge offering after that interview.
0 · Reply
MarlonJohn
MarlonJohn Jul. 19 at 7:24 PM
Retest validation! $JNJ triggers a perfect weekly breakout bounce as the healthcare titan shifts gears! Healthcare behemoth Johnson & Johnson ($JNJ) completes its tight technical consolidation, closing strong at $253.04 (+1.23% d/d) after touching an intraday peak of $255.66. Following a localized macro rotation out of high-beta tech, defensively minded capital is fortifying JNJ's structural base underneath its recent $269.43 high. Textbook macro technical framework! The weekly tape has executed a pristine breakout and retest sequence. After initially piercing its long-term overhead ceiling, the price underwent a highly constructive checkback to solidify the breakout zone as iron-clad demand shelf. Now that the weekly candle has officially registered a powerful reactive bounce from this inflection node, the bearish trap is verified closed. Velocity models indicate buying flow will naturally accelerate right-side momentum into a sustained short squeeze.
0 · Reply
Suite510
Suite510 Jul. 19 at 4:54 PM
$JNJ $KVUE In the past year alone, juries have awarded a $1.5 billion verdict in Baltimore, a $966 million verdict in Los Angeles later reduced to $16 million, a $40 million ovarian cancer verdict in Los Angeles, a $32 million mesothelioma verdict in Los Angeles, and a $65.5 million mesothelioma verdict in Minnesota—all finding that J&J's talccausing the plaintiffs' cancers.
1 · Reply
Suite510
Suite510 Jul. 19 at 4:52 PM
$JNJ $KVUE Shake n Bake Junk n Junk MDL talc trials start August 3rd in NJ 🤣🙈
1 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Jul. 19 at 4:03 PM
$SLS $MRK $ABBV $JNJ $PFE Part 3. I wouldn’t be surprised one ☝️ Bit if patent expiring in the tune of $380 Billion big pharmaceuticals make a move before Dr. Angelos Stergiou appearance at Fox and Friends. Once GPS CURATIVE news is televised on US # 1 News Network Show it will be hard to contain the SLS KRAKEN. Trading will be halted before any BO PR! ✌️🙏❤️‍🩹
0 · Reply
MarketPulsee
MarketPulsee Jul. 19 at 2:58 PM
12 Dividend Stocks For Beginners | Long-Term Income Watchlist Building wealth isn’t only about growth — consistent dividend income can also play an important role. Here are 12 established dividend stocks to watch: $JNJ Healthcare giant with a long dividend history $PG Consumer staples leader with defensive demand $KO Global beverage brand with steady cash flow $PEP Food and beverage powerhouse The best dividend stocks are not just high yield — they are companies that can continue growing and rewarding shareholders. Which dividend stocks do you own? Not financial advice. Always do your own research.
0 · Reply
beeelaaal
beeelaaal Jul. 19 at 12:58 PM
$VSTM $JNJ $LLYX.X $PFE https://asiaeconomictimes.com/post/77
0 · Reply
Ndellomo
Ndellomo Jul. 19 at 12:00 PM
$JNJ at $253, you’re buying one of the most durable healthcare franchises on earth at an apparent discount — if you believe the oncology pipeline can offset patent cliffs. https://stratafinance.beehiiv.com/p/johnson-johnson
0 · Reply
BillyBooker
BillyBooker Jul. 19 at 10:57 AM
$JNJ This keeps pulling me back
0 · Reply
JuggernautRaider
JuggernautRaider Jul. 18 at 9:29 PM
$NVO $GMAB keep joking bub. I have friends in congress and this is a nonpartisan issue believe it or not 🇺🇸 $LLY ans $JNJ do it right… but are also overvalued
0 · Reply
clan
clan Jul. 18 at 3:34 PM
$ELTP Elite is becoming more elite every day. ​👀 $JNJ $TEVA 👀 🇺🇲💪
0 · Reply
clan
clan Jul. 18 at 1:09 AM
$ELTP $TEVA $JNJ @LieutenantJoe Here comes another money-maker for Elite. 💲🐂
0 · Reply
HydrogenH2
HydrogenH2 Jul. 17 at 7:51 PM
$DJT $SPY $JNJ Interesting !! ...We talk about Epstein... Israel & FDA & JNJ baby powder & JFK !! https://www.youtube.com/watch?v=gxoPqY-CgGE
0 · Reply
RarelyRight
RarelyRight Jul. 17 at 6:45 PM
$ATAI Need $JNJ to come off the top rope with a $4.5 Billion all cash offer.
1 · Reply
Millionaire11
Millionaire11 Jul. 17 at 6:39 PM
$CMPS $JNJ acquision coming sooner than we think. Possibly before end of year. Just a prediction
1 · Reply
Tnitty4371
Tnitty4371 Jul. 17 at 5:25 PM
$SPY $DUOL 💵🎁💵🎁 $TSLA $META $JNJ
0 · Reply
Tnitty4371
Tnitty4371 Jul. 17 at 5:18 PM
$SPY 🎁💵🎁💵🎁 we are at the bottom $TSLA $META $QQQ $JNJ
0 · Reply